COMPANY-REPORTED CASE
VanTsteri's company account describes mycoplasma contamination during cell recovery at an anonymous hospital's cell culture facility. The account reports related mycoplasma findings in environmental samples and continued contamination after initial treatment.
The investigation considered culture media and serum, incubators, biological safety cabinets, cleaning practices and ventilation. The described response addressed process equipment, cold-storage equipment, the room environment and the HVAC system, alongside continued monitoring and discussions about hygiene controls.
The source reports that the combined investigation and environmental response brought the cell-room contamination problem under control. It provides no project-specific sample count, detection limit or measured log reduction.
It has not been confirmed whether this account and the other mycoplasma-related cell-facility account concern the same project. Equipment allocations and outcomes are not transferred between them.